Molly Hemenway, NP, PNP, MS
Pediatric Hematology / Oncology
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
720-777-1234
Provider Expertise
Clinical Interest for Patients
My clinical interests include children's brain tumors, end of life comfort care, clinical trials, and neurofibromatosis treatment options. I also enjoy teaching PA and PNP students.
Specialties
- Pediatric Hematology / Oncology
Conditions & Treatments
-
Cancers
Pediatric Cancer
-
Blood / Lymphatic System
Blood Disorders
Interests & Activities
Personal Interests
I enjoy spending time with my family, skiing, photography, and live music.
Volunteer Activities
I am dedicated to making the experience of children undergoing cancer therapy more tolerable and enjoyable. I am on the board of the Hinote's Heroes foundation.
Education & Training
Undergraduate Schools
BA, University of Puget Sound (WA) (1998)
BSN, University of Colorado - Health Sciences Center (CO) (2004)
Graduate Schools
ND, University of Colorado Health Sciences Center (2004)
MS, University of Colorado Health Sciences Center (2004)
Professional Memberships
APHON, Member
National Association of Pediatric Nurse Practitioners (NAPNAP), Member
Sigma Theta Tau, Member
Research & Grants
Grants
J. Patrick Barnes Grants For Nursing Research And Evidence-Based Practice Projects (2007)
Research Interests for Patients
My research interests include clinical pediatric neuro-oncology trials. I am also interested in parental experience of having a child treated on a Phase I/II clinical trial.
information for referring providers
Referral Contact Phone
(720) 777-6740
Clinical Interests for Referring Providers
My clinical interests include pediatric neuro-oncology, palliative care, experimental therapeutics, and neurofibromatosis therapeutics. I enjoy coordinating and precepting mid-level provider students within our department.
Research Interest for Referring Providers
My research interests include clinical pediatric neuro-oncology trials. I am also interested in parental experience of having a child treated on a Phase I/II clinical trial.
